|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Feb 1, 2025
|
FY2024
12 months to Feb 3, 2024
|
FY2023
12 months to Jan 28, 2023
|
FY2022
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment on equity investment | |||||
| Loss on early extinguishment of debt | |||||
| Loss on property disposals and impairment charges | |||||
| Deferred income tax provision (benefit) | |||||
| Share-based compensation | |||||
| Changes in assets and liabilities: | |||||
| (Increase) decrease in accounts receivable | |||||
| (Increase) in merchandise inventories | |||||
| Decrease (increase) in income taxes recoverable | |||||
| Increase in prepaid expenses and other current assets | |||||
| Increase in accounts payable | |||||
| Increase in accrued expenses and other liabilities | |||||
| Increase (decrease) in income taxes payable | |||||
| Increase (decrease) in net operating lease liabilities | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Property additions | |||||
| Purchase of equity investments | |||||
| Purchases of investments | |||||
| Sales and maturities of investments | |||||
| Net cash (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Payments for repurchase of common stock | |||||
| Proceeds from issuance of common stock | |||||
| Cash dividends paid | |||||
| Repayment of debt | |||||
| Other | |||||
| Net cash (used in) financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...
